InvestorsHub Logo
Followers 0
Posts 10
Boards Moderated 0
Alias Born 09/09/2018

Re: None

Friday, 12/07/2018 8:30:28 AM

Friday, December 07, 2018 8:30:28 AM

Post# of 9941
2 BILLION Dollars Bolsters Cronos Group's ability to be an innovation leader in the cannabis industry. Cronos Group's research collaborations with Gingko Bioworks to develop cultured cannabinoids and its partnership with the Technion Research and Development Foundation for cannabinoid-based skin care treatments are just two recent examples of how the Cronos Group intends to use innovation and its growing intellectual property portfolio to develop new applications for cannabinoids across a range of products and categories. Altria shares Cronos Group's commitment to innovation, medical cannabis research and state of the art product development.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INM News